Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Using annuities and stocks for retirement income explains blending these assets to diversify risk and stabilize cash flow for retirement.
28,656 articlesJohnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Insiders sold a meaningful block of stock at Select Water Solutions, yet the company still shows a strong growth stor...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...
Intel and TSMC reported divergent earnings trajectories as AI demand reshapes chips. This analysis weighs growth, mar...
Yield Guild Games is closing its YGG Play publishing arm and cutting 35 jobs as it pivots to artificial intelligence....
Resolute Holdings stock soars can signal a potent momentum move. This guide breaks down the drivers, evaluates sustai...
eXp Realty unveils a new division to help agents break into the new construction market. The program aims to close th...
TransFi has secured $19 million in funding to push its cross-border stablecoin payments platform into multiple region...
Two researchers are launching a dedicated effort to bring sustainability back into the AI conversation, promising mea...
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...
A veteran financial writer dives into a framework that aims to outpace the S&P over generations. Learn how Davis Fund...
Archer Aviation advances toward FAA Type Certification, with a looming Texas governance vote and a quarterly report t...